Target intelligence / Profile preview

Cellular plasma membrane and extracellular matrix components

Molecular classification
Other
01

Overview

The cellular plasma membrane and extracellular matrix (ECM) components represent the fundamental structural boundaries and microenvironmental framework of biological tissues. The plasma membrane is a dynamic phospholipid bilayer that houses essential proteins, including receptors, ion channels, and transporters, which are critical for maintaining cellular homeostasis and mediating response to external stimuli (Alberts et al., 2014). The ECM is an intricate network of macromolecules, such as collagen, proteoglycans, and glycoproteins, that provides physical scaffolding for cells and regulates diverse processes like adhesion, migration, and differentiation (Frantz et al., 2010). Together, these components play vital roles in tissue architecture and intercellular communication. Dysregulation of these components is a hallmark of diseases such as cancer metastasis and organ fibrosis, where the ECM undergoes significant remodeling to promote tumor progression (Yue, 2014). While numerous therapeutic agents target specific molecular entities within these structures, the category itself is too broad and heterogeneous to be defined as a single therapeutic target. Consequently, drug development typically focuses on discrete proteins or enzymes that operate within these compartments rather than the compartments themselves (Bonnans et al., 2014).

Other names
Cell surface and extracellular matrixPlasma membrane and ECMCellular boundary and microenvironment
02

Mechanism of action

Drugs associated with these components typically function by binding to cell-surface receptors to modulate signaling pathways, inhibiting adhesion molecules to prevent cell migration, or enzymatically modifying ECM proteins to alter tissue permeability and structure.

03

Biological functions

Cell adhesionSignal transductionStructural supportBarrier functionIntercellular communicationMechanotransduction
04

Disease associations

CancerFibrosisInflammationMetastatic diseaseCardiovascular disease
05

Safety considerations

Systemic toxicity due to ubiquitous expressionImpaired wound healingDisruption of normal tissue architectureVascular instability
06

Interacting drugs

Abciximab

4 more in the full profile.

07

Biomarkers

Matrix metalloproteinase (MMP) levelsSoluble E-cadherinCirculating collagen fragmentsFibronectin levels

Beyond the preview

Go deeper on Cellular plasma membrane and extracellular matrix components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular plasma membrane and extracellular matrix components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call